Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-11,739
Closed -$738K 1683
2021
Q4
$738K Sell
11,739
-21,811
-65% -$1.85M 0.03% 504
2021
Q3
$3.54M Buy
33,550
+12,450
+59% +$1.79M 0.13% 183
2021
Q2
$3.73M Buy
21,100
+12,753
+153% +$2.05M 0.09% 277
2021
Q1
$1.11M Buy
+8,347
New +$1.29M 0.03% 351

Other funds holding ZLAB

Ergoteles's ZLAB Position: Q1 2022 in Review

Ergoteles sold out of Zai Lab (ZLAB) in Q1 2022, closing a stake of 11,739 shares — an estimated $738K sold.

Ergoteles first reported a position in ZLAB in Q1 2021 and held it in 4 quarters. The position peaked at $3.73M in Q2 2021. 175 funds tracked by Wall St. Rank hold ZLAB as of Q1 2022.

  • Ergoteles reported no remaining Zai Lab position as of Q1 2022 after selling out during the quarter.
  • Ergoteles sold 11,739 Zai Lab shares in Q1 2022, an estimated $738K.
  • Ergoteles first reported a position in Zai Lab in Q1 2021 and held it in 4 quarters.
  • Ergoteles's Zai Lab position peaked at $3.73M in Q2 2021.
  • 175 funds tracked by Wall St. Rank held Zai Lab as of Q1 2022.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.